title: Does an endogenous methylpyridinium analogue cause Parkinson's disease?
authors.forename: B
authors.initials: B
authors.lastname: Testa
authors.forename: R
authors.initials: R
authors.lastname: Naylor
authors.forename: B
authors.initials: B
authors.lastname: Costall
authors.forename: P
authors.initials: P
authors.lastname: Jenner
authors.forename: C D
authors.initials: CD
authors.lastname: Marsden
mesh_terms: D015632:1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; D055598:Chemical Phenomena; D002621:Chemistry; D006801:Humans; D008745:Methylation; D010300:Parkinson Disease / Q000209:etiology* / Q000378:metabolism; D011725:Pyridines / Q000378:metabolism* / Q000502:physiology
chemical_list: D011725:Pyridines; D015632:1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine